Login / Signup

Cyclodextrin inclusion complexes improving antibacterial drug profiles: an update systematic review.

Anamaria Mendonça SantosJosé Adão Carvalho Nascimento JuniorSilvia Vs CézarAdriano Antunes de Souza AraújoLucindo José Quintans-JuniorDiana Marcela AragónMairim Russo Serafini
Published in: Future microbiology (2023)
Aim: The study aimed to review experimental models using cyclodextrins to improve antibacterial drugs' physicochemical characteristics and biological activities. Methods: The following terms and their combinations were used: cyclodextrins and antibacterial agents in title or abstract, and the total study search was conducted over a period up to October 2022. The review was carried out using PubMed, Scopus and Embase databases. A total of 1580 studies were identified, of which 27 articles were selected for discussion in this review. Results: The biological results revealed that the antibacterial effect of the inclusion complexes was extensively improved. Cyclodextrins can enhance the therapeutic effects of antibiotics already existing on the market, natural products and synthetic molecules. Conclusion: Overall, CDs as drug-delivery vehicles have been shown to improve antibiotics solubility, stability, and bioavailability, leading to enhanced antibacterial activity.
Keyphrases